Department of Cellular Pathology, Royal Free London NHS Foundation Trust; University College London; London, UK.
Department of Pathology, Hospital Cuf Descobertas, Lisboa and Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.
J Crohns Colitis. 2024 Feb 26;18(2):175-191. doi: 10.1093/ecco-jcc/jjad142.
Histological assessment of endoscopic biopsies in inflammatory bowel disease [IBD] plays an important role in clinical management, investigative studies, and clinical trials. Scoring schemes consisting of multiple histological items and offering considerable precision are widely available. However, definitions of histological abnormalities are often inconsistent. Furthermore, interobserver variability for their recognition and assessment may be high. The European Crohn's and Colitis Organisation [ECCO] formed an expert panel to explore definitions of histological abnormalities in IBD, with the aim of improving the quality of diagnosis and facilitating development of scoring schemes. The process confirmed that the current definitions often have no evidence base and vary between sources. Using available evidence and expert knowledge, the panel produced a series of ECCO consensus position statements on histological features in IBD.
在炎症性肠病(IBD)的临床管理、研究和临床试验中,内镜活检的组织学评估起着重要作用。广泛应用的评分方案包括多个组织学项目,具有较高的精确性。然而,组织学异常的定义往往不一致。此外,其识别和评估的观察者间变异性可能很高。欧洲克罗恩病和结肠炎组织(ECCO)成立了一个专家小组,探讨 IBD 中的组织学异常定义,旨在提高诊断质量,促进评分方案的发展。该过程证实,目前的定义通常没有证据基础,并且在不同来源之间存在差异。专家组利用现有证据和专业知识,就 IBD 的组织学特征制定了一系列 ECCO 共识立场声明。